Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Clinical Breast Cancer|June 28, 2006
Concordance between central and local laboratory HER2 testing from a community-based clinical studyJosina C Reddy, James D Reimann, Steven M Anderson, et al.Seminars in Oncology|November 13, 2003
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancerMelody A Cobleigh, Virginia K Langmuir, George W Sledge, et al.Ophthalmology|May 12, 2005
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degenerationPhilip J Rosenfeld, Steven D Schwartz, Mark S Blumenkranz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancerKathy D Miller, Linnea I Chap, Frankie A Holmes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancerAdrian M Jubb, Kathy D Miller, Hope S Rugo, et al.Pageof 1